BRPI0607666A2 - misturas de lipìdeo polar, sua preparação e uso - Google Patents

misturas de lipìdeo polar, sua preparação e uso

Info

Publication number
BRPI0607666A2
BRPI0607666A2 BRPI0607666-1A BRPI0607666A BRPI0607666A2 BR PI0607666 A2 BRPI0607666 A2 BR PI0607666A2 BR PI0607666 A BRPI0607666 A BR PI0607666A BR PI0607666 A2 BRPI0607666 A2 BR PI0607666A2
Authority
BR
Brazil
Prior art keywords
preparation
polar lipid
lipid mixtures
mixtures
polar
Prior art date
Application number
BRPI0607666-1A
Other languages
English (en)
Inventor
Avidor Shulman
Rassan Zuabi
Gai Ben Dror
Yoni Twito
Dori Pelled
Yael Herzog
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36645701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0607666(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of BRPI0607666A2 publication Critical patent/BRPI0607666A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)

Abstract

MISTURAS DE LIPìDEO POLAR, SUA PREPARAçãO E USO. A presente invenção refere-se a misturas de lipídeo polar, compreendendo glicerofosfolipídeos tais como fosfatidilcolina (PC), fosfatidjietanolamina (PE), fosfatidilserina (PS) e fosfatidil-inositol (PI), e esfingolipídeos tais como esfingomielina (SM). O mais importante, a relação de fosfolipídeos em dita mistura é comparável àquela de HMF, e é representada por SM > PC> PE> PS> PI ou SM = PC> PE> PS> PI. Os processos para a preparação da ditas misturas e seu uso são também aqui descritos.
BRPI0607666-1A 2005-04-28 2006-04-27 misturas de lipìdeo polar, sua preparação e uso BRPI0607666A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL16829405 2005-04-28
PCT/IL2006/000510 WO2006114790A2 (en) 2005-04-28 2006-04-27 Polar lipid mixtures, their preparation and uses

Publications (1)

Publication Number Publication Date
BRPI0607666A2 true BRPI0607666A2 (pt) 2009-09-22

Family

ID=36645701

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607666-1A BRPI0607666A2 (pt) 2005-04-28 2006-04-27 misturas de lipìdeo polar, sua preparação e uso

Country Status (7)

Country Link
US (2) US20090011075A1 (pt)
EP (2) EP2382872A1 (pt)
CN (1) CN101316521B (pt)
BR (1) BRPI0607666A2 (pt)
IL (2) IL186928A (pt)
RU (1) RU2480474C2 (pt)
WO (1) WO2006114790A2 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158139A0 (en) * 2003-09-25 2004-09-27 Enzymotec Ltd Stabilized formulations of phosphatidyl serine
US9095507B2 (en) 2011-08-11 2015-08-04 Allergy Research Group, Llc Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
US8877239B2 (en) * 2010-08-12 2014-11-04 Nutritional Therapeutics, Inc. Lipid supplements for maintaining health and treatment of acute and chronic disorders
US9468668B2 (en) 2011-08-11 2016-10-18 Allergy Research Group, Llc Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders
NZ583662A (en) * 2007-08-17 2012-04-27 Murray Goulburn Coop Co Ltd Compositions comprising phospholipids
CN101902918A (zh) * 2007-10-19 2010-12-01 方塔拉合作集团有限公司 保持或增加成长或认知发育的方法
AU2008318291A1 (en) * 2007-10-31 2009-05-07 The University Of Sydney Treatment of metabolic disease
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
MY160275A (en) 2008-09-02 2017-02-28 Nutricia Nv Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2010107325A1 (en) * 2009-03-17 2010-09-23 Macgibbon Alastair Kenneth Hugh Satiety product
WO2011115476A1 (en) * 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US11253531B2 (en) 2011-08-11 2022-02-22 Nutritional Therapeutics, Inc. Lipid supplements for reducing nerve action potentials
US10117885B2 (en) 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
JP5701371B2 (ja) * 2012-12-28 2015-04-15 花王株式会社 スフィンゴミエリン含有サプリメント
US9661874B2 (en) * 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) * 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US20140255537A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
CN103262893B (zh) * 2013-06-13 2014-11-05 俞祖勋 一种改善智力的配方奶粉
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
RU2678418C1 (ru) 2013-12-12 2019-01-28 Нестек С.А. Искусственные молочные композиции для оптимального роста, развития и профилактики ожирения у младенцев и детей младшего возраста мужского и женского пола
EP3079770B1 (en) * 2013-12-12 2020-05-13 Société des Produits Nestlé S.A. Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity
US20170273343A1 (en) 2014-08-15 2017-09-28 N.V. Nutricia Lipid composition for improving behaviour
CN105746729B (zh) * 2014-12-17 2021-11-30 丰益(上海)生物技术研发中心有限公司 乳化剂组合物及其用途
ES2750308T3 (es) 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
US11986445B2 (en) 2015-12-14 2024-05-21 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting myelination of the brain
WO2017102720A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
BR112018010278A2 (pt) * 2015-12-14 2018-11-27 Nestec Sa composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN108366602A (zh) * 2015-12-14 2018-08-03 雀巢产品技术援助有限公司 促进大脑髓鞘形成的营养组合物和婴儿配方食品
PT3389407T (pt) 2015-12-14 2024-01-19 Nestle Sa Composição nutricional e fórmula para lactentes para promover mielinização de novo
CN108697671A (zh) * 2016-03-30 2018-10-23 雀巢产品技术援助有限公司 包含胆碱的组合物及其用途
CN108367013A (zh) * 2016-03-30 2018-08-03 雀巢产品技术援助有限公司 包含磷脂的组合物及其用途
CA3003651A1 (en) * 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising fatty acids and their use
AU2017373837B2 (en) 2016-12-09 2022-07-14 N.V. Nutricia Nutritional composition for improving cell membranes
CN110294774A (zh) * 2019-06-18 2019-10-01 宁波大学 一种富含鞘磷脂的脂质的制备方法
CN112385845A (zh) * 2019-08-12 2021-02-23 丰益(上海)生物技术研发中心有限公司 一种富含opo的结构化乳液
CN113115841A (zh) * 2019-12-30 2021-07-16 丰益(上海)生物技术研发中心有限公司 含磷脂的婴儿配方乳
CN114680198A (zh) * 2020-12-29 2022-07-01 丰益(上海)生物技术研发中心有限公司 配方乳用油脂组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62179351A (ja) * 1986-01-31 1987-08-06 Showa Sangyo Kk レシチンの製造法
JP2805522B2 (ja) * 1989-04-25 1998-09-30 雪印乳業株式会社 乳または乳製品由来のリン脂質画分を分画精製する方法
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
SE501697C2 (sv) * 1993-02-11 1995-04-24 Svenska Mejeriernas Riksforeni Förfarande för utvinning av sfingomyelin
JPH07173182A (ja) * 1993-12-17 1995-07-11 Meiji Milk Prod Co Ltd リン脂質を主成分とする乳由来の極性脂質の抽出方法及び濃縮方法
DE4420295C1 (de) 1994-06-10 1995-10-26 Riedhammer Gmbh Co Kg Durchlaufofen
JP3497355B2 (ja) 1997-10-06 2004-02-16 信越フィルム株式会社 シリコンの精製方法
US6949528B1 (en) * 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
IL150240A (en) * 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements

Also Published As

Publication number Publication date
US20110294757A1 (en) 2011-12-01
US9814252B2 (en) 2017-11-14
IL186928A (en) 2016-02-29
IL186928A0 (en) 2008-02-09
IL243998A0 (en) 2016-04-21
WO2006114790A3 (en) 2007-05-31
CN101316521A (zh) 2008-12-03
US20090011075A1 (en) 2009-01-08
CN101316521B (zh) 2014-06-25
RU2480474C2 (ru) 2013-04-27
EP2382872A1 (en) 2011-11-02
EP1898722A2 (en) 2008-03-19
WO2006114790A2 (en) 2006-11-02
RU2007144104A (ru) 2009-06-10
EP1898722B1 (en) 2013-04-10

Similar Documents

Publication Publication Date Title
BRPI0607666A2 (pt) misturas de lipìdeo polar, sua preparação e uso
Kooijman et al. Biophysics and function of phosphatidic acid: a molecular perspective
Kimura et al. Roles of specific lipid species in the cell and their molecular mechanism
Fuller et al. The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes
Milne et al. A targeted mass spectrometric analysis of phosphatidylinositol phosphate species
Speelmans et al. The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration
Térová et al. On the importance of the phosphocholine methyl groups for sphingomyelin/cholesterol interactions in membranes: a study with ceramide phosphoethanolamine
Lähdesmäki et al. Membrane simulations mimicking acidic pH reveal increased thickness and negative curvature in a bilayer consisting of lysophosphatidylcholines and free fatty acids
Toyran et al. Competitive effect of vitamin D2 and Ca2+ on phospholipid model membranes: an FTIR study
CO6260056A2 (es) Composiciones de liposomas para administracion in vivo de compuestos de acido boronico
Graber et al. Phosphatidylinositol-4, 5-bisphosphate ionization in the presence of cholesterol, calcium or magnesium ions
Graber et al. Phosphatidylinositol-4, 5-bisphosphate ionization and domain formation in the presence of lipids with hydrogen bond donor capabilities
IL193966A (en) Phospholipid Complexes and Corcumin Extracts, a Process for their Preparation and Pharmaceutical Preparations
RU2012157015A (ru) Способ двухфазного получения липосом и способы их применения при изготовлении диагностических реагентов
Bolean et al. The effect of cholesterol on the reconstitution of alkaline phosphatase into liposomes
WO2005038037A3 (en) Methods for preparing phospholipids containing omega-3 and omega-6 moieties
JP2015519383A5 (pt)
Benvegnu et al. Archaeosomes based on novel synthetic tetraether-type lipids for the development of oral delivery systems
Fiore The synthesis of mono-alkyl phosphates and their derivatives: an overview of their nature, preparation and use, including synthesis under plausible prebiotic conditions
Gomide et al. Disrupting membrane raft domains by alkylphospholipids
BR112013005069A2 (pt) Uso de uma preparação para a fabricação de um produto para a prevenção ou o tratamento de ansiedade ou depressão
Eriksson et al. Effect of ubiquinone-10 on the stability of biomimetic membranes of relevance for the inner mitochondrial membrane
CY1117006T1 (el) Ν-[4-(1Η-ΠΥΡΑΖΟΛΟ[3,4-b|ΠΥΡΑΖΙΝ-6-ΥΛ)-ΦΑΙΝΥΛ]-ΣΟΥΛΦΟΝΑΜΙΔΕΣ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ
Palacios-Ortega et al. Regulation of sticholysin II-induced pore formation by lipid bilayer composition, phase state, and interfacial properties
Heczková et al. Effect of anti-tumor ether lipids on ordered domains in model membranes

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23J 7/00 (2006.01), A23L 33/115 (2016.01), A61P 2

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2515 DE 19-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.